HCP Live (2/6, Derman) reports, “Lurasidone is linked to improving social functioning in patients with schizophrenia, a new study found.” The researchers “leveraged data from a multicenter, randomized, double-blind, placebo-controlled, parallel-group 6-week JEWEL study which started in May 2016 and ended in November 2018, as well as a subsequent 12-week open-label extension study to evaluate longer-term changes.” The findings were published in the Journal of Clinical Psychiatry.
Related Links:
— “Lurasidone Linked to Improving Social Functioning for Schizophrenia,”Chelsie Derman, HCP Live, February 6, 2024